Understanding Neurodegeneration
Neurodegeneration refers to the progressive dysfunction and loss of neurons. When neurons die, the functions they control—such as movement, memory, and cognition—decline, leading to the clinical syndromes observed in various disorders.
Selective Vulnerability
Not all neurons are equally susceptible. Certain types of neurons are more vulnerable, which explains why each disease produces a characteristic pattern of symptoms.
Key Brain Structures and Their Roles
- Cerebellum: Coordinates movement and maintains balance.
- Hippocampus: Essential for memory formation and thinking.
- Basal ganglia: Controls voluntary movement.
- Substantia nigra: Supplies dopamine to the basal ganglia for smooth motion.
Comparing Brain Regions
The hippocampus is primarily involved in memory, whereas the basal ganglia manage voluntary movement. This distinction helps differentiate disorders such as Alzheimer disease (memory‑focused) from Parkinson disease (movement‑focused).
Proteinopathies: Diseases of Abnormal Protein Accumulation
Many neurodegenerative disorders are classified as proteinopathies, where misfolded proteins aggregate into toxic clumps.
- Alzheimer disease – extracellular amyloid‑beta deposits (amyloid plaques) and intracellular hyperphosphorylated tau protein (neurofibrillary tangles).
- Parkinson disease – Lewy bodies containing α‑synuclein.
- Frontotemporal degeneration – TDP‑43 protein aggregates.
- Huntington disease – expanded polyglutamine tract in huntingtin protein.
- Friedreich ataxia – deficiency of frataxin, a mitochondrial protein.
- Creutzfeldt‑Jakob disease – misfolded prion protein that induces further misfolding of normal PrP.
Alzheimer Disease
Alzheimer disease is the most common cause of dementia in older adults. Early stages primarily affect the hippocampus, impairing new memory formation, while later stages involve widespread cortical atrophy. Grossly, the brain shows narrowed gyri, widened sulci, and enlarged ventricles (ex vacuo).
Frontotemporal Degeneration (FTD)
FTD often presents with behavioral changes before memory loss. Abnormal TDP‑43 protein clumps are a hallmark in many cases.
Parkinson Disease (PD)
PD is characterized by loss of dopaminergic neurons in the substantia nigra, leading to bradykinesia, rigidity, and tremor. Lewy bodies, composed of α‑synuclein, are the characteristic protein aggregates. Levodopa can increase brain dopamine and improve motor symptoms, but it does not halt neuronal loss.
Huntington Disease (HD)
HD results from an expanded CAG repeat in the HTT gene, producing a huntingtin protein with an elongated polyglutamine tract. The disease is autosomal dominant; longer repeat lengths correlate with earlier onset. Motor signs are dominated by chorea, contrasting with the rigidity of PD.
Spinocerebellar Ataxias (SCAs) vs. Friedreich Ataxia
SCAs are caused by dominant CAG repeat expansions, whereas Friedreich ataxia is a recessive disorder due to mutations in the FXN gene, leading to low frataxin levels and mitochondrial dysfunction.
Amyotrophic Lateral Sclerosis (ALS)
ALS is a progressive disease marked by loss of both upper and lower motor neurons. Upper motor neuron loss produces spasticity and brisk reflexes; lower motor neuron loss causes muscle atrophy and fasciculations. The disease does not affect only lower motor neurons.
Prion Diseases
Abnormal prion proteins propagate disease by inducing misfolding of normal PrP, creating a self‑amplifying cascade. Creutzfeldt‑Jakob disease, a prion disease, leads to rapidly progressive dementia with little to no inflammation in brain tissue.
Clinical Comparisons
| Disease | Early Symptom | Primary Affected Region | Key Protein |
|---|---|---|---|
| Alzheimer disease | Memory difficulty | Hippocampus → later cortex | Amyloid‑beta, hyperphosphorylated tau |
| Parkinson disease | Slowed movement | Substantia nigra | α‑synuclein (Lewy bodies) |
| Huntington disease | Chorea | Striatum | Polyglutamine‑expanded huntingtin |
| Frontotemporal degeneration | Behavioral changes | Frontal & temporal cortex | TDP‑43 |
| Creutzfeldt‑Jakob disease | Rapidly progressive dementia | Diffuse cortical involvement | Misfolded prion protein |
Key Takeaways
- Neurodegeneration is defined by progressive neuronal loss, leading to functional decline.
- Selective vulnerability determines which symptoms dominate each disease.
- Protein aggregation (proteinopathy) is a common pathogenic mechanism across many disorders.
- Understanding the sequence of brain region involvement aids early diagnosis (e.g., hippocampal loss in early Alzheimer disease).
- Genetic mechanisms vary: repeat expansions (HD, SCAs), recessive gene loss (Friedreich ataxia), and prion conformational change (CJD).


